GlassScriptPhysician profile
Amanda Mudrey Bartell
NPI 1366429862
$3,631.31
in general payments reported to CMS, 2019-2025
11 companies · $1,458 in 2025
The $1,458 reported for 2025 was more than what 86% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $17.63 · 2021: $31.48 · 2022: $1,894 · 2023: $118 · 2025: $1,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,299 · Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,298.51 |
| Food and Beverage | $277.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,235.41 | 2022-2025 | |
| Wright Medical Technology, INC. | $111.53 | 2019 | |
| Stryker Corporation | $87.26 | 2020-2023 | Prostep |
| Zimvie INC. | $57.92 | 2022 | |
| Paratek Pharmaceuticals, INC. | $31.30 | 2025 | Nuzyra |
| Bioventus LLC | $23.72 | 2022 | |
| Biowound Solutions, INC. | $19.72 | 2025 | Bio-Connekt |
| Smith+Nephew, INC. | $16.58 | 2022 | |
| Averitas Pharma INC. | $16.39 | 2023 | Qutenza |
| Heron Therapeutics, INC. | $16.12 | 2021 | |
| Apria Healthcare LLC | $15.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Bartell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.